```html

Zygotic Twin Discordance – A Comprehensive Medical Guide

Overview

Zygotic twin discordance (often abbreviated as “twin discordance”) refers to a situation in which one twin in a dizygotic (fraternal) pair experiences a different intra‑uterine environment, growth pattern, or health status than the co‑twin. The term “discordance” is applied when there is a measurable difference—most commonly in birth weight, size, or organ development—greater than what is expected for normal fraternal twins.

• Who it affects: Any pregnancy carrying dizygotic twins, regardless of maternal age, race, or socioeconomic status. While the condition can occur in both singleton‑derived and IVF‑derived twins, some studies suggest a slightly higher incidence in assisted reproductive technology (ART) pregnancies.
• Prevalence: Twin discordance is reported in 10–25 % of dizygotic twin pregnancies, with severe discordance (≥25 % difference in birth weight) occurring in 4–8 % of cases. (CDC, Mayo Clinic).

Symptoms

Because discordance primarily reflects differences in growth or physiology, the “symptoms” are usually identified by clinical assessment rather than patient‑reported complaints. The key findings include:

During Pregnancy

• Abnormal growth curves on ultrasound: One twin’s estimated fetal weight (EFW) falls below the 10th percentile while the co‑twin remains within or above the 90th percentile.
• Amniotic fluid inequality: Polyhydramnios (excess fluid) around one twin and oligohydramnios (low fluid) around the other.
• Different Doppler waveforms: Abnormal umbilical artery or middle cerebral artery Doppler studies in the smaller twin suggest placental insufficiency.
• Maternal symptoms: Increased abdominal pain, uterine contractions, or vaginal bleeding may signal complications such as twin‑to‑twin transfusion syndrome (TTTS), which is a form of discordance more common in monochorionic twins but can coexist with dizygotic discordance when placental sharing is unequal.

After Birth

• Birth weight discordance: A weight difference of ≥20‑25 % between twins. For example, one twin weighing 3.0 kg and the other 2.1 kg.
• Growth restriction signs in the smaller twin: Poor postnatal weight gain, low head circumference, or failure to thrive.
• Respiratory distress: More common in the growth‑restricted twin due to underdeveloped lungs.
• Neurological signs: Irritability, feeding difficulties, or lethargy, potentially reflecting hypoxic injury.
• Cardiovascular abnormalities: Hypertension or patent ductus arteriosus can appear more frequently in the larger twin due to relative over‑circulation.

Causes and Risk Factors

Discordance is not a disease itself but a manifestation of underlying placental, vascular, or genetic issues.

Placental Factors

• Unequal placental sharing: In dizygotic twins each placenta may be separate (dichorionic) or share a common placenta (partial monochorionic). Unequal distribution of blood flow can limit nutrients to one twin.
• Placental infarction or insufficiency: Ischemic lesions may affect one side more than the other.

Vascular Factors

• Umbilical cord abnormalities: One twin may have a single umbilical artery, a velamentous insertion, or true knots that impair blood flow.
• Maternal vascular disease: Hypertension, pre‑eclampsia, or diabetes can exacerbate placental insufficiency.

Genetic & Chromosomal Factors

• Growth‑related gene variants: Differences in insulin‑like growth factor (IGF) pathways can cause divergent growth.
• Chromosomal aneuploidy in one twin: Turner syndrome or trisomy 21 may lead to growth restriction.

Maternal & Environmental Risk Factors

• Maternal age > 35 years (higher risk of placental abnormalities).
• Smoking, alcohol, or illicit drug use during pregnancy.
• Pre‑existing hypertension, chronic kidney disease, or autoimmune disorders.
• Assisted reproductive technologies – especially when multiple embryos are transferred.

Diagnosis

Early detection relies on routine prenatal care and targeted imaging.

Ultrasound

• Standard bi‑weekly anatomy scans: Measure each twin’s biometric parameters (head circumference, abdominal circumference, femur length).
• Doppler studies: Evaluate blood flow in umbilical arteries and middle cerebral arteries.
• Placental assessment: Look for separate vs. shared placental territories, infarcts, or abnormal vascular anastomoses.

Maternal Serum Markers

• Elevated pregnancy‑associated plasma protein A (PAPP‑A) or decreased placental growth factor (PlGF) may hint at placental insufficiency.

Fetal Monitoring

• Non‑stress tests (NST) or biophysical profiles (BPP) performed more frequently if discordance is suspected.

Post‑natal Assessment

• Precise birth weight measurement and percentile calculation.
• Screening for anemia, hypoglycemia, or metabolic disturbances in the smaller twin.
• Genetic testing if a chromosomal abnormality is suspected (e.g., microarray, karyotype).

Treatment Options

Management is individualized, based on gestational age, severity of discordance, and underlying cause.

Expectant Management

• Close surveillance with ultrasound every 1–2 weeks.
• Maternal optimization—control blood pressure, glucose, and avoid smoking.

Pharmacologic Interventions

• Aspirin 81 mg daily: Recommended for women at risk of placental insufficiency (American College of Obstetricians and Gynecologists, ACOG). May improve uteroplacental blood flow.
• Corticosteroids (betamethasone 12 mg IM, 24 h apart): Given between 24–34 weeks gestation to accelerate fetal lung maturity if early delivery is contemplated.
• Low‑dose heparin: Considered in cases with documented placental vascular pathology, though evidence is limited.

Procedural Options

• Selective reduction: In rare, severe discordance where one twin is non‑viable and threatens the healthier twin, percutaneous cord occlusion may be offered.
• Laser photocoagulation: Primarily for monochorionic twins with twin‑to‑twin transfusion; occasionally useful if hidden anastomoses are identified in dizygotic twins.
• Timing of delivery: Early delivery (e.g., 34–36 weeks) may be indicated for severe growth restriction, abnormal Dopplers, or maternal indications.

Neonatal Care

• NICU admission for the smaller twin for temperature regulation, respiratory support, and nutrition.
• Intravenous glucose to prevent hypoglycemia.
• Transfusion of packed red blood cells if anemia is present.

Living with Zygotic Twin Discordance (medical)

Families often need both medical guidance and practical strategies to cope.

For Parents

• Education: Understand growth charts and the meaning of discordance percentages.
• Regular appointments: Keep all prenatal visits; ask the provider to review each twin’s growth individually.
• Nutrition: A balanced diet rich in protein, iron, calcium, and omega‑3 fatty acids supports placental health.
• Stress reduction: Mind‑body techniques (prenatal yoga, meditation) may improve maternal blood pressure.
• Support groups: Many hospitals host twin‑specific support groups; emotional sharing reduces anxiety.

For the Twins After Birth

• Follow-up growth measurements every 2–4 weeks until the smaller twin catches up.
• Breast‑feeding on demand or fortified formula to meet higher caloric needs.
• Early developmental screening (e.g., Bayley Scales) to detect neuro‑developmental delays.

Prevention

Because many causes are not fully controllable, prevention focuses on modifiable maternal risk factors and optimal prenatal care.

• Pre‑conception health: Achieve a healthy weight (BMI 18.5–24.9), manage chronic hypertension or diabetes, and cease smoking/alcohol.
• Avoid unnecessary multiple embryo transfers: Work with fertility specialists who follow elective single‑embryo transfer guidelines.
• Early prenatal screening: First‑trimester ultrasound for chorionicity and early detection of placental anomalies.
• Low‑dose aspirin prophylaxis: 81 mg daily starting at 12‑16 weeks for women with a history of placental disorders (per ACOG).
• Maternal nutrition supplementation: Prenatal vitamins containing folic acid, iron, and DHA.

Complications

If discordance is severe and unmanaged, several complications can arise:

• Intrauterine growth restriction (IUGR) of the smaller twin, leading to low birth weight and increased neonatal mortality.
• Preterm birth: Placental insufficiency often prompts early delivery, with the attendant risks of respiratory distress syndrome and intraventricular hemorrhage.
• Neurodevelopmental impairment: Chronic hypoxia may affect cognition, language, and motor skills.
• Cardiovascular sequelae: Hypertension or cardiac remodeling in the larger twin due to relative over‑circulation.
• Maternal complications: Severe pre‑eclampsia, placental abruption, or postpartum hemorrhage.

When to Seek Emergency Care

Prompt medical attention can prevent serious outcomes for both mother and twins.

---

Sources: Mayo Clinic, CDC, ACOG, NIH NICHD, Cleveland Clinic. ```